{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:38:16Z","timestamp":1792852696840,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drudis.2014.05.018","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T08:35:10Z","timestamp":1401698110000},"page":"1454-1458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Factor XI as a target for antithrombotic therapy"],"prefix":"10.1016","volume":"19","author":[{"suffix":"Jr.","given":"Charles E.","family":"Bane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2014.05.018_bib0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","article-title":"Structure and function of factor XI","volume":"115","author":"Emsley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0010","series-title":"The Online Metabolic and Molecular Basis of Inherited Disease","article-title":"Factor XI and the contact system","author":"Gailani","year":"2010"},{"key":"10.1016\/j.drudis.2014.05.018_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.thromres.2011.11.051","article-title":"Factor XI: hemostasis, thrombosis and antithrombosis","volume":"129","author":"He","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.drudis.2014.05.018_bib0020","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1538-7836.2010.04031.x","article-title":"Coagulation factor XI as a novel target for antithrombotic treatment","volume":"8","author":"L\u00f6wenberg","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0025","series-title":"Hematology: Basic Principles and Practice","first-page":"1174","article-title":"Overview of hemostasis","author":"Weitz","year":"2013"},{"key":"10.1016\/j.drudis.2014.05.018_bib0030","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.drudis.2014.05.018_bib0035","series-title":"Hematology: Basic Principles and Practice","first-page":"1939","article-title":"Rare coagulation factor deficiencies","author":"Gailani","year":"2013"},{"key":"10.1016\/j.drudis.2014.05.018_bib0040","series-title":"Hematology: Basic Principles and Practice","first-page":"2067","article-title":"Antithrombotic drugs","author":"Weitz","year":"2013"},{"key":"10.1016\/j.drudis.2014.05.018_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3810\/pgm.2013.07.2683","article-title":"Novel oral anticoagulants: a review of new agents","volume":"125","author":"Wanat","year":"2013","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.drudis.2014.05.018_bib0050","doi-asserted-by":"crossref","first-page":"38200","DOI":"10.1074\/jbc.M112.376343","article-title":"A sequential mechanism for exosite-mediated factor IX activation by factor XIa","volume":"287","author":"Geng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.05.018_bib0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","article-title":"Activation of factor XI by products of prothrombin activation","volume":"118","author":"Matafonov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0033-1353420","article-title":"Congenital factor XI deficiency: an update","volume":"39","author":"Duga","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2516.2006.01304.x","article-title":"Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy","volume":"12","author":"Salomon","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.drudis.2014.05.018_bib0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2014.05.018_bib0075","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682","article-title":"High levels of factor IX increase the risk of venous thrombosis","volume":"95","author":"van Hylckama Vlieg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0080","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/QC259F09UNMKVP0R","article-title":"Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events","volume":"126","author":"Yang","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.drudis.2014.05.018_bib0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH10-05-0307","article-title":"Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis","volume":"105","author":"Salomon","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0095","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"Salomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0100","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2005.01236.x","article-title":"Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice","volume":"3","author":"Wang","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0110","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2008-06-163675","article-title":"Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI","volume":"113","author":"Tucker","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renn\u00e9","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2014.05.018_bib0120","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/jth.12275","article-title":"Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa","volume":"11","author":"Geng","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0125","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.12435","article-title":"Evidence for factor IX-independent roles for factor XIa in blood coagulation","volume":"11","author":"Matafonov","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0130","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0135","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","article-title":"Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0140","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/ATVBAHA.113.301282","article-title":"Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates","volume":"33","author":"Crosby","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.drudis.2014.05.018_bib0145","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0150","article-title":"ISIS-FXIRx, a novel and specific antisense inhibitor of factor XI, caused significant reduction in FXI antigen and activity and increased aPTT without causing bleeding in healthy volunteers","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0155","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.bmcl.2006.07.043","article-title":"Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa","volume":"16","author":"Lazarova","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2014.05.018_bib0160","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.bmcl.2006.02.052","article-title":"Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an alpha-ketothiazole arginine","volume":"16","author":"Deng","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2014.05.018_bib0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-011-0599-0","article-title":"A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits","volume":"32","author":"Wong","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.drudis.2014.05.018_bib0170","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/jm401670x","article-title":"Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors","volume":"57","author":"Quan","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2014.05.018_bib0175","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/jm301757v","article-title":"Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site","volume":"56","author":"Karuturi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2014.05.018_bib0180","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jth.12414","article-title":"Factor XI anion-binding sites are required for productive interactions with polyphosphate","volume":"11","author":"Geng","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2014.05.018_bib0185","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/jm301338q","article-title":"Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa","volume":"56","author":"Al-Horani","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2014.05.018_bib0190","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/jm800314b","article-title":"Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa","volume":"51","author":"Buchanan","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2014.05.018_bib0195","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2013-08-517474","article-title":"Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo","volume":"122","author":"Ma","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2014.05.018_bib0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2741\/3926","article-title":"Tissue factor pathway inhibitor: structure-function","volume":"17","author":"Broze","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.drudis.2014.05.018_bib0205","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/bi00222a008","article-title":"Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains","volume":"30","author":"McMullen","year":"1991","journal-title":"Biochemistry"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614002256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614002256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:20:39Z","timestamp":1761222039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644614002256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1359644614002256"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2014.05.018","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor XI as a target for antithrombotic therapy","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2014.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}